127 related articles for article (PubMed ID: 33413755)
1. Trastuzumab-Induced Severe Thrombocytopenia:A Case Report and Literature Review.
Zeng XQ; Jiang SS; Peng YY; Liu MF; Ye CS; Dong JY
Chin Med Sci J; 2020 Dec; 35(4):377-382. PubMed ID: 33413755
[TBL] [Abstract][Full Text] [Related]
2. Gradual thrombocytopenia induced by long-term trastuzumab exposure.
Miarons M; Velasco M; Campins L; Fernández S; Gurrera T; Lopez-Viaplana L
J Clin Pharm Ther; 2016 Oct; 41(5):563-5. PubMed ID: 27425556
[TBL] [Abstract][Full Text] [Related]
3. Severe thrombocytopenia induced by trastuzumab rechallenge: a case report and literature review.
Wang X; Zhu X; Zou J; Zhang X; Kong X; Nie J
J Clin Pharm Ther; 2021 Aug; 46(4):1173-1177. PubMed ID: 33735519
[TBL] [Abstract][Full Text] [Related]
4. Severe thrombocytopenia after trastuzumab retreatment: a case report.
Pino MS; Angiolini C; Fioretto L
BMC Res Notes; 2013 Oct; 6():400. PubMed ID: 24093447
[TBL] [Abstract][Full Text] [Related]
5. Severe thrombocytopenia related to trastuzumab infusion.
Mantzourani M; Gogas H; Katsandris A; Meletis J
Med Sci Monit; 2011 Jul; 17(7):CS85-7. PubMed ID: 21709639
[TBL] [Abstract][Full Text] [Related]
6. Severe thrombocytopenia induced by a single infusion of trastuzumab.
Parikh O; Neave F; Palmieri C
Clin Breast Cancer; 2008 Jun; 8(3):285-6. PubMed ID: 18650161
[TBL] [Abstract][Full Text] [Related]
7. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
[TBL] [Abstract][Full Text] [Related]
8. Severe thrombocytopenia possibly associated with TMP/SMX therapy.
Yamreudeewong W; Fosnocht BJ; Weixelman JM
Ann Pharmacother; 2002 Jan; 36(1):78-82. PubMed ID: 11816265
[TBL] [Abstract][Full Text] [Related]
9. [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].
Wang XY; Feng FY; Song ST; Wang HQ; Zhang MH; Liu J; Liu XY; Xu LG; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):373-6. PubMed ID: 16117903
[TBL] [Abstract][Full Text] [Related]
10. Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage.
Gerotziafas GT; Zervas C; Gavrielidis G; Tokmaktsis A; Hatjiharissi E; Papaioannou M; Lazaridou A; Constantinou N; Samama MM; Christakis J
Am J Hematol; 2002 Mar; 69(3):219-22. PubMed ID: 11891811
[TBL] [Abstract][Full Text] [Related]
11. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
12. Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.
Diéras V; Miles D; Verma S; Pegram M; Welslau M; Baselga J; Krop IE; Blackwell K; Hoersch S; Xu J; Green M; Gianni L
Lancet Oncol; 2017 Jun; 18(6):732-742. PubMed ID: 28526536
[TBL] [Abstract][Full Text] [Related]
13. Thrombocytopenia Induced by Herceptin.
Luo Q; Guo Z; Ye C
Am Surg; 2019 Apr; 85(4):e222-e224. PubMed ID: 31043221
[No Abstract] [Full Text] [Related]
14. Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial.
Krop IE; Kim SB; Martin AG; LoRusso PM; Ferrero JM; Badovinac-Crnjevic T; Hoersch S; Smitt M; Wildiers H
Lancet Oncol; 2017 Jun; 18(6):743-754. PubMed ID: 28526538
[TBL] [Abstract][Full Text] [Related]
15. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
[TBL] [Abstract][Full Text] [Related]
16. Severe thrombocytopenia induced by second exposure to trastuzumab can be alleviated by prolonging the interval between treatments.
Zeng RC; Dai XX; Xie FY; Chen ED; Qu JM; Hu XQ
Clin Breast Cancer; 2014 Apr; 14(2):e69-72. PubMed ID: 24388532
[No Abstract] [Full Text] [Related]
17. [Effectiveness and safety of recombinant human interleukin-11 in the treatment of chemotherapy-induced thrombocytopenia].
Lei W; Liang J; Chen WG; Ma XZ; Xu M; Du LL
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):542-4. PubMed ID: 17147124
[TBL] [Abstract][Full Text] [Related]
18. A Case Report of Drug-Induced Thrombocytopenia after Living Donor Liver Transplantation.
Arai K; Kuramitsu K; Fukumoto T; Kido M; Takebe A; Tanaka M; Kinoshita H; Ajiki T; Toyama H; Asari S; Goto T; Ku Y
Kobe J Med Sci; 2016 Jun; 62(1):E9-E12. PubMed ID: 27492209
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietic activity of recombinant human interleukin-11 in nonhuman primates with ACNU-induced thrombocytopenia.
Saitoh M; Taguchi K; Yasuda S; Kikumori M; Nishimori T; Suda M; Okamiya H; Usuda S; Miyata K
J Interferon Cytokine Res; 2000 Jun; 20(6):539-45. PubMed ID: 10888110
[TBL] [Abstract][Full Text] [Related]
20. Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature.
Taira F; Horimoto Y; Saito M
Breast Cancer; 2015 Nov; 22(6):664-8. PubMed ID: 23420376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
